Because we already had a process in place for agreeing cancer drugs via NECDAG in the region, we were able to bring our experiences together to work in an innovative and collaborative way and ensure more patients can access potentially life-enhancing drugs, fairly, quickly and when they need ...
CancerCare is pleased to announce the availability of co-payment assistance for people diagnosed with multiple myeloma through the CancerCare Co-Payment Assistance Foundation.
摘要: Publication » PO34 FUNDING PRIORITIES FOR CANCER RESEARCH IN USA – AN ADVOCACY INITIATIVE TO GAUGE PERCEPTION OF METASTATIC BREAST CANCER RESEARCH AND FUNDING AMONGST CANCER RESEARCHERS IN THE USA.DOI: 10.1016/S0960-9776(13)70047-X 年份: 2013 ...
In the Unite States, sufficient federal government funding is "vital if we are to accelerate the pace of progress against cancer for the benefit of patients and their loved ones everywhere," Foti said. The conference is sponsored by the AACR, the EORTC and the U.S. National Cancer Institute...
GIST Cancer Support & Information for when you need it... Personal Support » Community Support » Share experiences with others online or at our regular patient/carer meetings GISTs & Treatments » Find out more about this rare cancer and its treatment ...
Led by CEO James Cook, Evergreen Theragnostics is focused on improving the available options for cancer patients using radiopharmaceuticals. The financing advances the company’s novel discovery pipeline into clinical trials, supports commercialization of its diagnostic agent, and further expands Contract ...
Coalition Priorité Cancer and the pharmaceutical industry in Quebec: conflicts of interest in the reimbursement of expensive cancer drugs? Healthc Policy. 2013;9(1):52-64.PubMedGoogle Scholar 10. Herxheimer A. Relationships between the pharmaceutical industry and patients’ organisations. BMJ. ...
"The decline in NIH funding that we have seen since 2004 threatens the pace of progress and undermines the promise of cures for patients," said Dr. Jose Baselga, AACR president and physician-in-chief at Memorial Sloan Kettering Cancer Center, in New York City. ...
"It shows just how promising pelareorep treatment can be for extending the lives of breast cancer patients. This is further exemplified by the near doubling of the 2-year survival rate for patients who received pelareorep combination therapy." These promising results mi...
For children with cancer(癌),the facts of life include the facts of death. There is always the fear that they might not live to grow up.Yet they realize that fighting cancer is the only way of beating it. So they fight.And sometimes, they win.It may t